A long term, randomized clinical trial to evaluate the effects of ramipril on the evolution of renal function in chronic nephropathies

Giuseppe Remuzzi; G Tognoni; P. Ruggenenti; Annalisa Perna; Q. Maggiorre; Francesco Pizzarelli; Francesca Schena; G Mecca; Erica Daina; G. Maiorca; Francesco Scolari; R. Rossi; Mariangela Ferradini; Maurizio Salvadori; L Minetti; Giuseppe D’Amico; F. Vendemmia; Carmine Zoccali; Giorgina Barbara Piccoli

Related publications

Article1998

Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial

Piero Ruggenenti, Annalisa Perna, Giulia Gherardi, Flavio Gaspari, Roberto Benini, Giuseppe Remuzzi

Article2019

TCT-610 Impact of Baseline Renal Function on the Long-Term Clinical Outcomes After PCI: Insights From a Prespecified Subgroup Analysis of the Randomized GLOBAL LEADERS Trial

Mariusz Tomaniak, Ply Chichareon, Dominika Klimczak‐Tomaniak, Norihiro Kogame, Rodrigo Modolo, Kuniaki Takahashi, Chun‐Chin Chang, Hidenori Komiyama, Tessa Rademaker‐Havinga, Nick Curzen, Michael Haude, Christian W. Hamm, Philippe Gabríel Steg, Peter Jüni, Yoshinobu Onuma, Pascal Vranckx, Marco Valgimigli, Stephan Windecker, Richard Anderson, Patrick W. Serruys

Journal of the American College of Cardiology

Article2004

The way to cardio-renal protection in non-diabetic chronic nephropathies

Piero Ruggenenti, Giuseppe Remuzzi, Mario Negri, Giuseppe Remuzzi

Article2004

Treating anemia early in renal failure patients slows the decline of renal function: A randomized controlled trial

Chariclia Gouva, Petros Nikolopoulos, John P A Ioannidis, Kostas C. Siamopoulos

Article2013

Percutaneous revascularization and long term clinical outcomes of diabetic patients randomized in the Occluded Artery Trial (OAT)

Christopher B. Overgaard, Vladimír Džavík, Christopher E. Buller, Li Liu, Waldemar Banasiak, Gerard Devlin, Aldo Maggioni, Jonathan Leor, J. R. Burton, Gilmar Reis, Witold Rużyłło, Sandra Forman, Gervasio A. Lamas, Judith S. Hochman